Med-Chemist : "Quintessential Medicinal Chemistry"
Friday, November 10, 2017
'Intelligent' nanoparticles could help treat cancer patients
›
Scientists from the University of Surrey have developed 'intelligent' nanoparticles which heat up to a temperat...
Thursday, November 9, 2017
FDA Approves Once-Weekly Bydureon BCise (exenatide) for Patients with Type-2 Diabetes
›
In continuation of my update on exenatide . AstraZeneca announced that the US Food and Drug Administration (FDA) has approved ...
Tuesday, November 7, 2017
New molecule could become first treatment against chemotherapy-induced neuropathy
›
IDIBELL Researchers of the Neuro-Oncology Unit of Bellvitge University Hospital - Catalan Institute of Oncology, led by Dr. Jordi Br...
Monday, November 6, 2017
Yoga can be beneficial to people with lung cancer and their caregivers
›
In a feasibility trial of people with advanced lung cancer receiving radiation therapy, and their caregivers, yoga was beneficial to bot...
Friday, November 3, 2017
FDA Approves Ascor (Ascorbic Acid Injection, USP) for the Treatment of Scurvy
›
McGuff Pharmaceuticals, Inc., a wholly owned subsidiary of McGuffCompany, Inc. announces the United States Food and Drug Administration’s ...
Thursday, November 2, 2017
FDA Approves Verzenio (abemaciclib) for Certain Advanced or Metastatic Breast Cancers
›
We know that, Abemaciclib is a kinase inhibitor for oraladministration. It is a white to yellow powder with the empirical formul...
Friday, October 27, 2017
Dietary supplement could be promising therapeutic target for seizure disorders
›
We know that, Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and l...
Monday, October 16, 2017
Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis Knee Pain
›
In continuation of my update on Zilretta Flexion Therapeutics, Inc. announced, that Food and Drug Administration (FDA) approv...
Friday, October 13, 2017
FDA Approves Lyrica CR (pregabalin) Extended-Release Tablets for Neuropathic Pain Conditions
›
In continuation of my update on Pregabalin Pfizer Inc. announced today that the Food and Drug Administration (FDA) has approved Lyrica CR ...
‹
›
Home
View web version